Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia

NCT ID: NCT02787122

Last Updated: 2020-03-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

64 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-01-01

Study Completion Date

2017-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present study is a pilot single-blind randomized controlled therapy study. Its aim is to assess the efficacy of an emotion-focussed form of Cognitive behavior Therapy that focusses on emotional processes that are involved in the formation and maintenance of delusions such as emotional stability, emotion regulation and self-esteem.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cognitive Behavior Therapy for psychosis (CBTp) is an effective treatment for patients with psychosis. Several meta-analyses showed an effect of CBTp in addition to antipsychotic treatment of small to medium effect size with regard to positive symptoms, general psychopathology and depression. Nevertheless, present research suggests that are especially emotional processes are closely related to positive symptoms and delusions, such as negative emotions, low self-esteem, depression and anxiety, whereas present interventions of CBTp focus often especially on cognitive interventions in order to change delusions as well as more cognitive risk factors for delusions such as reasoning biases and a dysfunctional causal attribution style.

Thus, the aim of the present single-blind randomized-controlled pilot therapy study was to assess the efficacy of a new form of emotion-focussed Cognitive behavior therapy for psychosis with regard to change in positive symptoms and delusions in comparison to standard treatment.

The main hypotheses are:

\- Efficacy of CBT-E: patients with schizophrenia who receive CBT-E show a more pronounced reduction of delusions (primary outcome), as well as a more pronounced reduction of positive symptoms, depression and general psychopathology, a stronger improvement in general and social functioning and will receive lower doses of antipsychotic medication (secondary outcomes) at post-treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Schizophrenia Delusional Disorder Schizoaffective Disorder Brief Psychotic Disorder Schizophreniform Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The CBT-E group receives 15-25 sessions of cognitive behavior therapy with a special focus on emotion regulation (CBT-E), the wait list group receives CBT-E after six month waiting time
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
Blinded rating of diagnostic interviews

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CBT-E

Emotion-focussed Cognitive behavior therapy:

Patients receive 25 sessions of individual emotion-focused Cognitive Behavior Therapy. Interventions are behavioral activation, training of emotion regulation strategies, improvement of self-esteem and relapse prevention.

Group Type ACTIVE_COMPARATOR

CBT-E

Intervention Type BEHAVIORAL

Patients receive 25 sessions of individual emotion-focused Cognitive Behavior Therapy based on a manual. Interventions aim on patients' mood by implementing positive activities in their daily routine. Further, patients train to reduce worrying behavior. Social contacts are fostered as well. Later, patients are informed on emotions and train emotion regulation strategies. Finally, the focus of CBT-E is on self-acceptance.Patients receive psychoeducation on self-acceptance and learn strategies in order to reduce negative self-schema and foster positive self-schema.

Treatment as Usual

Patients who are randomized and assigned to the Wait list are required to wait for half a year, while they receive standardized care (antipsychotic medication). After half a year, they receive CBT-E, as well.

Group Type PLACEBO_COMPARATOR

Treatment as Usual

Intervention Type BEHAVIORAL

Patients receive standardized treatment. After a waiting period of six month, patients receive CBT-E

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CBT-E

Patients receive 25 sessions of individual emotion-focused Cognitive Behavior Therapy based on a manual. Interventions aim on patients' mood by implementing positive activities in their daily routine. Further, patients train to reduce worrying behavior. Social contacts are fostered as well. Later, patients are informed on emotions and train emotion regulation strategies. Finally, the focus of CBT-E is on self-acceptance.Patients receive psychoeducation on self-acceptance and learn strategies in order to reduce negative self-schema and foster positive self-schema.

Intervention Type BEHAVIORAL

Treatment as Usual

Patients receive standardized treatment. After a waiting period of six month, patients receive CBT-E

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Emotion-focused Cognitive Behavior Therapy

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of schizophrenia, schizoaffective disorder, delusional disorder or brief psychotic disorder
* Positive and Negative Syndrome Scale score in item P1 (delusions) of at least two
* fluent in German language
* agree to participate
* estimated general intelligence of at least 70 (assessed with the German Wortschatztest (MWT-B)
* no present suicidality

Exclusion Criteria

* acute suicidality
* comorbid diagnosis of borderline personality disorder and/or substance use disorder in the last six month
* intake of Benzodiazepines
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Hamburg-Eppendorf

OTHER

Sponsor Role collaborator

Philipps University Marburg

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Prof. Dr. Stephanie Mehl

Prof. Dr. rer. nat.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stephanie Mehl, Ph. D.

Role: PRINCIPAL_INVESTIGATOR

Philipps University Marburg

Tania M. Lincoln

Role: PRINCIPAL_INVESTIGATOR

University of Hamburg-Eppendorf

Winfried Rief

Role: STUDY_DIRECTOR

Philipps University Marburg

Tilo Kircher

Role: STUDY_DIRECTOR

Philipps University Marburg

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Marburg, Faculty of Clinical Psychology and Psychotherapy

Marburg, Hesse, Germany

Site Status

University of Hamburg, Faculty of Clinical Psychology and Psychotherapy

Hamburg, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CBT-E_MehlLincoln

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mobile CBT for Negative Symptoms
NCT03621774 COMPLETED NA
Peer-led Psycho-education for Schizophrenia
NCT03246932 ACTIVE_NOT_RECRUITING NA